Abstract
We have previously reported that pretreatment with carrageenan (CAR) enhances lipopolysaccharide (LPS)induced tumor necrosis factor alpha (TNF- α) production in and lethality for mice. Whole blood cultured in vitro was used to show that CAR pretreatment results in about a 200-fold increase in LPS-induced TNF-α production. CAR by itself did not induce TNF-α production. However, CAR-treated cultured medium sensitized whole blood to make more LPS-induced TNF than did saline-treated cultured medium in vitro. It was also demonstrated that CAR pretreatment increases TNF-α mRNA levels of both blood cells and peritoneal exudate cells, but not of bone marrow cells. Immunoelectron microscopic analysis revealed that polymorphonuclear leukocytes and macrophages are TNF-α-producing cells in CAR-treated mice. In CAR-treated mice, TNF-α was seen early after LPS injection in leukocytes in hepatic sinusoids and on the surfaces of endothelial cells. TNF-α was also detected late after LPS injection in hepatocytes which become edematous. These results suggest that CAR primes leukocytes to produce TNF-α in response to LPS and that they play an important role in the pathogenesis of liver injury.
Cite
CITATION STYLE
Ogata, M., Matsui, T., Kita, T., & Shigematsu, A. (1999). Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production. Infection and Immunity, 67(7), 3284–3289. https://doi.org/10.1128/iai.67.7.3284-3289.1999
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.